61 results
8-K
GYRE
Gyre Therapeutics Inc
2 Nov 23
Changes in Registrant's Certifying Accountant
5:00pm
Report on Form 8-K.
(b) Engagement of Independent Registered Public Accounting Firm
On the Closing Date, the Audit Committee engaged Grant Thornton
S-8
EX-99.1
GYRE
Gyre Therapeutics Inc
30 Oct 23
Registration of securities for employees
5:46pm
such agents, trustees, brokers, depositories and advisors and determine such terms of their engagement as it shall deem appropriate for the proper … in Control shall apply to the Grantees (including, without limitation, appointment and engagement of a stockholders’ or sellers’ representative, payment
8-K
EX-10.2
GYRE
Gyre Therapeutics Inc
30 Oct 23
Entry into a Material Definitive Agreement
5:17pm
such agents, trustees, brokers, depositories and advisors and determine such terms of their engagement as it shall deem appropriate for the proper … in Control shall apply to the Grantees (including, without limitation, appointment and engagement of a stockholders’ or sellers’ representative, payment
DEFM14A
c6zugfjmfb4f v6uz
20 Jul 23
Proxy related to merger
8:57am
CORRESP
u9sevix
26 Jun 23
Correspondence with SEC
12:00am
PRER14A
yqn0czod
15 May 23
Preliminary revised proxy
4:02pm
PREM14A
e2mtba
30 Mar 23
Preliminary proxy related to merger
4:48pm
425
EX-2.1
2wln3xb03j veca3v4
27 Dec 22
Business combination disclosure
7:02am
425
EX-2.2
oajt irb5jg7lfj
27 Dec 22
Business combination disclosure
7:02am
8-K
EX-2.1
hznp 6el6ayhm0s
27 Dec 22
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
7:00am
8-K
EX-2.2
ti0e5
27 Dec 22
Catalyst Biosciences Completes First Steps in Reverse Merger Plan
7:00am
8-K
EX-99.1
th0ncjcw a2dlm9miz
19 Aug 22
Other Events
9:13am
8-K
EX-99.1
kojgg3lr7mgb it1b9
1 Aug 22
Other Events
8:32am
DEFC14A
ntmd uelned
20 Jul 22
Proxy in contested solicitation
9:16am
DEFC14A
fpq94x fv3
19 Jul 22
Proxy in contested solicitation
8:01am